OSMT - Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q3 2021 Results - Earnings Call Transcript

Osmotica Pharmaceuticals plc (OSMT) Q3 2021 Earnings Conference Call November 15, 2021, 04:30 PM ET Company Participants Lisa Wilson - IR Brian Markison - CEO Andrew Einhorn - CFO JD Schaub - COO Conference Call Participants David Steinberg - Jefferies Greg Fraser - Truist Securities Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the Osmotica Q3 2021 Earnings Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to hand the conference over to your host, Ms. Lisa Wilson. Ma'am, you may begin. Lisa Wilson Thank you, Christian. Welcome to Osmotica Pharmaceuticals' third quarter 2021 business update call. This is Lisa Wilson, Investor Relations for Osmotica. With me on today's call are Osmotica's Chief Executive Officer, Brian Markison; Chief Operating Officer, JD Schaub; and Chief Financial Officer, Andy Einhorn. This afternoon the company issued a press release detailing financial results for the

For further details see:

Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q3 2021 Results - Earnings Call Transcript